{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:47:55Z","timestamp":1790801275445,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T00:00:00Z","timestamp":1232409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/ncpgasthep1340","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T08:47:13Z","timestamp":1232441233000},"page":"92-106","source":"Crossref","is-referenced-by-count":98,"title":["Diagnosis and management of fistulizing Crohn's disease"],"prefix":"10.1038","volume":"6","author":[{"given":"Ole Haagen","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Rogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Hahnloser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole \u00d8stergaard","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,20]]},"reference":[{"key":"BFncpgasthep1340_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.gtc.2004.03.002","volume":"33","author":"TA Judge","year":"2004","unstructured":"Judge TA and Lichtenstein GR (2004) Treatment of fistulizing Crohn's disease. Gastroenterol. Clin North Am 33: 421\u2013454","journal-title":"Gastroenterol. Clin North Am"},{"key":"BFncpgasthep1340_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/gut.21.6.525","volume":"21","author":"G Hellers","year":"1980","unstructured":"Hellers G et al. (1980) Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut 21: 525\u2013527","journal-title":"Gut"},{"key":"BFncpgasthep1340_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/gast.2002.32362","volume":"122","author":"DA Schwartz","year":"2002","unstructured":"Schwartz DA et al. (2002) The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 122: 875\u2013880","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s003840050051","volume":"11","author":"MJ Solomon","year":"1996","unstructured":"Solomon MJ (1996) Fistulae and abscesses in symptomatic perianal Crohn's disease. Int J Colorectal Dis 11: 222\u2013226","journal-title":"Int J Colorectal Dis"},{"key":"BFncpgasthep1340_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0016-5085(03)00877-1","volume":"125","author":"WJ Sandborn","year":"2003","unstructured":"Sandborn WJ et al. (2003) Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 125: 380\u2013388","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR6","doi-asserted-by":"crossref","unstructured":"American Gastroenterological Association Clinical Practice Committee (2003) American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 125: 1503\u20131507","DOI":"10.1016\/S0016-5085(03)01060-6"},{"key":"BFncpgasthep1340_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF02054227","volume":"38","author":"PR Williamson","year":"1995","unstructured":"Williamson PR et al. (1995) Twenty-year review of the surgical management of perianal Crohn's disease. Dis Colon Rectum 38: 389\u2013392","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR8","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s10350-007-9191-2","volume":"51","author":"AJ Ky","year":"2008","unstructured":"Ky AJ et al. (2008) Collagen fistula plug for the treatment of anal fistulas. Dis Colon Rectum 51: 838\u2013843","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR9","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1053\/gast.2001.28676","volume":"121","author":"DA Schwartz","year":"2001","unstructured":"Schwartz DA et al. (2001) A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 121: 1064\u20131072","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF02552656","volume":"28","author":"HC Kuijpers","year":"1985","unstructured":"Kuijpers HC and Schulpen T (1985) Fistulography for fistula-in-ano. Is it useful? Dis Colon Rectum 28: 103\u2013104","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR11","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s10620-005-2769-4","volume":"50","author":"RL West","year":"2005","unstructured":"West RL et al. (2005) Perianal fistulas in Crohn's disease are predominantly colonized by skin flora: implications for antibiotic treatment? Dig Dis Sci 50: 1260\u20131263","journal-title":"Dig Dis Sci"},{"key":"BFncpgasthep1340_CR12","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1136\/gut.2003.038208","volume":"53","author":"F Bataille","year":"2004","unstructured":"Bataille F et al. (2004) Morphological characterisation of Crohn's disease fistulae. Gut 53: 1314\u20131321","journal-title":"Gut"},{"key":"BFncpgasthep1340_CR13","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.gastro.2003.07.004","volume":"125","author":"SN Leeb","year":"2003","unstructured":"Leeb SN et al. (2003) Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase. Gastroenterology 125: 1341\u20131354","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1572-0241.2004.04044.x","volume":"99","author":"SN Leeb","year":"2004","unstructured":"Leeb SN et al. (2004) Autocrine fibronectin-induced migration of human colonic fibroblasts. Am J Gastroenterol 99: 335\u2013340","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep1340_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/00054725-200102000-00014","volume":"7","author":"AU Dignass","year":"2001","unstructured":"Dignass AU (2001) Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis 7: 68\u201377","journal-title":"Inflamm Bowel Dis"},{"key":"BFncpgasthep1340_CR16","first-page":"G729","volume":"271","author":"M Goke","year":"1996","unstructured":"Goke M et al. (1996) Regulation and function of extracellular matrix intestinal epithelial restitution in vitro. Am J Physiol 271: G729\u2013G740","journal-title":"Am J Physiol"},{"key":"BFncpgasthep1340_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/BF01213309","volume":"32","author":"DK Podolsky","year":"1997","unstructured":"Podolsky DK (1997) Healing the epithelium: solving the problem from two sides. J Gastroenterol 32: 122\u2013126","journal-title":"J Gastroenterol"},{"issue":"Suppl 1","key":"BFncpgasthep1340_CR18","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1007\/s10620-005-2803-6","volume":"50","author":"AS Tarnawski","year":"2005","unstructured":"Tarnawski AS (2005) Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci 50 (Suppl 1): S24\u2013S33","journal-title":"Dig Dis Sci"},{"key":"BFncpgasthep1340_CR19","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R and Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776\u20131784","journal-title":"J Clin Invest"},{"key":"BFncpgasthep1340_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1083\/jcb.200601018","volume":"172","author":"JM Lee","year":"2006","unstructured":"Lee JM et al. (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973\u2013981","journal-title":"J Cell Biol"},{"key":"BFncpgasthep1340_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0092-8674(01)00365-8","volume":"105","author":"AM Arias","year":"2001","unstructured":"Arias AM (2001) Epithelial mesenchymal interactions in cancer and development. Cell 105: 425\u2013431","journal-title":"Cell"},{"key":"BFncpgasthep1340_CR22","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ceb.2003.10.006","volume":"15","author":"JP Thiery","year":"2003","unstructured":"Thiery JP (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740\u2013746","journal-title":"Curr Opin Cell Biol"},{"key":"BFncpgasthep1340_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00004836-199501000-00008","volume":"20","author":"EJ Irvine","year":"1995","unstructured":"Irvine EJ (1995) Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 20: 27\u201332","journal-title":"J Clin Gastroenterol"},{"key":"BFncpgasthep1340_CR24","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH et al. (1999) Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 340: 1398\u20131405","journal-title":"N Engl J Med"},{"key":"BFncpgasthep1340_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/gast.2002.31072","volume":"122","author":"WJ Sandborn","year":"2002","unstructured":"Sandborn WJ et al. (2002) A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 122: 512\u2013530","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR et al. (1976) Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70: 439\u2013444","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR27","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJM198005013021801","volume":"302","author":"DH Present","year":"1980","unstructured":"Present DH et al. (1980) Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 302: 981\u2013987","journal-title":"N Engl J Med"},{"key":"BFncpgasthep1340_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1046\/j.1365-2036.2003.01793.x","volume":"18","author":"C Dejaco","year":"2003","unstructured":"Dejaco C et al. (2003) Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 18: 1113\u20131120","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep1340_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/00054725-200403000-00005","volume":"10","author":"S Ardizzone","year":"2004","unstructured":"Ardizzone S et al. (2004) Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm Bowel Dis 10: 91\u201396","journal-title":"Inflamm Bowel Dis"},{"key":"BFncpgasthep1340_CR30","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2004","unstructured":"Sands BE et al. (2004) Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350: 876\u2013885","journal-title":"N Engl J Med"},{"key":"BFncpgasthep1340_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncpgasthep0696","volume":"4","author":"OH Nielsen","year":"2007","unstructured":"Nielsen OH and Munck LK (2007) Drug insight: aminosalicylates for the treatment of IBD. Nat Clin Pract Gastroenterol Hepatol 4: 160\u2013170","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"BFncpgasthep1340_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/gut.7.2.181","volume":"7","author":"JH Jones","year":"1966","unstructured":"Jones JH and Lennard-Jones JE (1966) Corticosteroids and corticotrophin in the treatment of Crohn's disease. Gut 7: 181\u2013187","journal-title":"Gut"},{"key":"BFncpgasthep1340_CR33","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/BF02233943","volume":"11","author":"M Sparberg","year":"1966","unstructured":"Sparberg M and Kirsner JB (1966) Long-term corticosteroid therapy for regional enteritis: an analysis of 58 courses in 54 patients. Am J Dig Dis 11: 865\u2013880","journal-title":"Am J Dig Dis"},{"key":"BFncpgasthep1340_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0016-5085(84)90409-8","volume":"86","author":"H Malchow","year":"1984","unstructured":"Malchow H et al. (1984) European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 86: 249\u2013266","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5085(82)80332-6","volume":"83","author":"LJ Brandt","year":"1982","unstructured":"Brandt LJ et al. (1982) Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 83: 383\u2013387","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR36","first-page":"533","volume":"79","author":"J Jakobovits","year":"1984","unstructured":"Jakobovits J and Schuster MM (1984) Metronidazole therapy for Crohn's disease and associated fistulae. Am J Gastroenterol 79: 533\u2013540","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep1340_CR37","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1055\/s-2008-1069077","volume":"110","author":"MU Schneider","year":"1985","unstructured":"Schneider MU et al. (1985) Metronidazole in the treatment of Crohn disease. Results of a controlled randomized prospective study [German]. Dtsch Med Wochenschr 110: 1724\u20131730","journal-title":"Dtsch Med Wochenschr"},{"key":"BFncpgasthep1340_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0016-5085(80)90155-9","volume":"79","author":"LH Bernstein","year":"1980","unstructured":"Bernstein LH et al. (1980) Healing of perineal Crohn's disease with metronidazole. Gastroenterology 79: 357\u2013365","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR39","first-page":"602","volume":"30","author":"C Prantera","year":"1998","unstructured":"Prantera C et al. (1998) Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol 30: 602\u2013606","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"BFncpgasthep1340_CR40","first-page":"A793","volume":"104","author":"U Turunen","year":"1993","unstructured":"Turunen U et al. (1993) Long-term outcome of ciprofloxacin treatment in severe perianal or fistulous Crohn's disease [abstract]. Gastroenterology 104: A793","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR41","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/j.1365-2036.2004.02247.x","volume":"20","author":"RL West","year":"2004","unstructured":"West RL et al. (2004) Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 20: 1329\u20131336","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep1340_CR42","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1046\/j.1365-2036.2001.01102.x","volume":"15","author":"OH Nielsen","year":"2001","unstructured":"Nielsen OH et al. (2001) Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther 15: 1699\u20131708","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep1340_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/BF01318372","volume":"30","author":"BI Korelitz","year":"1985","unstructured":"Korelitz BI and Present DH (1985) Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci 30: 58\u201364","journal-title":"Dig Dis Sci"},{"key":"BFncpgasthep1340_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0016-5085(91)90457-V","volume":"101","author":"JJ O'Brien","year":"1991","unstructured":"O'Brien JJ et al. (1991) Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gastroenterology 101: 39\u201346","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","volume":"123","author":"DC Pearson","year":"1995","unstructured":"Pearson DC et al. (1995) Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 123: 132\u2013142","journal-title":"Ann Intern Med"},{"key":"BFncpgasthep1340_CR46","doi-asserted-by":"publisher","first-page":"A1113","DOI":"10.1016\/S0016-5085(98)84526-5","volume":"114","author":"SC Wheeler","year":"1998","unstructured":"Wheeler SC et al. (1998) Medical therapy, not surgery is the appropriate first line of treatment for Crohn's enterovesical fistula. Gastroenterology 114: A1113","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00004836-198908000-00010","volume":"11","author":"ML Margolin","year":"1989","unstructured":"Margolin ML and Korelitz BI (1989) Management of bladder fistulas in Crohn's disease. J Clin Gastroenterol 11: 399\u2013402","journal-title":"J Clin Gastroenterol"},{"key":"BFncpgasthep1340_CR48","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/BF02554563","volume":"32","author":"AJ Greenstein","year":"1989","unstructured":"Greenstein AJ et al. (1989) Gastric fistulas in Crohn's disease. Report of cases. Dis Colon Rectum 32: 888\u2013892","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR49","first-page":"1198","volume":"88","author":"BI Korelitz","year":"1993","unstructured":"Korelitz BI et al. (1993) Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease. Am J Gastroenterol 88: 1198\u20131205","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep1340_CR50","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/gut.48.5.642","volume":"48","author":"C Cuffari","year":"2001","unstructured":"Cuffari C et al. (2001) Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut 48: 642\u2013646","journal-title":"Gut"},{"key":"BFncpgasthep1340_CR51","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1572-0241.1998.00442.x","volume":"93","author":"LJ Egan","year":"1998","unstructured":"Egan LJ et al. (1998) Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine. Am J Gastroenterol 93: 442\u2013448","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep1340_CR52","first-page":"646","volume":"88","author":"SB Hanauer","year":"1993","unstructured":"Hanauer SB and Smith MB (1993) Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A. Am J Gastroenterol 88: 646\u2013649","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep1340_CR53","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/BF02090211","volume":"39","author":"DH Present","year":"1994","unstructured":"Present DH and Lichtiger S (1994) Efficacy of cyclosporine in treatment of fistula of Crohn's disease. Dig Dis Sci 39: 374\u2013380","journal-title":"Dig Dis Sci"},{"key":"BFncpgasthep1340_CR54","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00004836-199909000-00009","volume":"29","author":"SR Gurudu","year":"1999","unstructured":"Gurudu SR et al. (1999) Cyclosporine therapy in inflammatory bowel disease: short-term and long-term results. J Clin Gastroenterol 29: 151\u2013154","journal-title":"J Clin Gastroenterol"},{"key":"BFncpgasthep1340_CR55","volume-title":"Cochrane Database of Systematic Reviews","author":"JW McDonald","year":"2005","unstructured":"McDonald JW et al. Cyclosporine for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD000297"},{"key":"BFncpgasthep1340_CR56","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2165\/00003495-200059020-00021","volume":"59","author":"GL Plosker","year":"2000","unstructured":"Plosker GL and Foster RH (2000) Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 59: 323\u2013389","journal-title":"Drugs"},{"key":"BFncpgasthep1340_CR57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0016-5085(95)90277-5","volume":"109","author":"HM van Dullemen","year":"1995","unstructured":"van Dullemen HM et al. (1995) Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109: 129\u2013135","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0140-6736(08)60995-2","volume":"372","author":"L Peyrin-Biroulet","year":"2008","unstructured":"Peyrin-Biroulet L et al. (2008) Crohn's disease: beyond antagonists of tumour necrosis factor. Lancet 372: 67\u201381","journal-title":"Lancet"},{"key":"BFncpgasthep1340_CR59","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S1542-3565(04)00414-8","volume":"2","author":"BE Sands","year":"2004","unstructured":"Sands BE et al. (2004) Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study. Clin Gastroenterol Hepatol 2: 912\u2013920","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFncpgasthep1340_CR60","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1053\/j.gastro.2005.01.048","volume":"128","author":"GR Lichtenstein","year":"2005","unstructured":"Lichtenstein GR et al. (2005) Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 128: 862\u2013869","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2036.2007.03553.x","volume":"27","author":"VS Theis","year":"2008","unstructured":"Theis VS and Rhodes JM (2008) Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease. Aliment Pharmacol Ther 27: 19\u201330","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep1340_CR62","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","volume":"130","author":"SB Hanauer","year":"2006","unstructured":"Hanauer SB et al. (2006) Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology 130: 323\u2013333","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR63","doi-asserted-by":"publisher","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","volume":"146","author":"WJ Sandborn","year":"2007","unstructured":"Sandborn WJ et al. (2007) Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Ann Intern Med 146: 829\u2013838","journal-title":"Ann Intern Med"},{"key":"BFncpgasthep1340_CR64","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","volume":"132","author":"JF Colombel","year":"2007","unstructured":"Colombel JF et al. (2007) Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 132: 52\u201365","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR65","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC and Sandborn WJ (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369: 1641\u20131657","journal-title":"Lancet"},{"key":"BFncpgasthep1340_CR66","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1056\/NEJMoa067594","volume":"357","author":"WJ Sandborn","year":"2007","unstructured":"Sandborn WJ et al. (2007) Certolizumab pegol for the treatment of Crohn's disease. N Engl J Med 357: 228\u2013238","journal-title":"N Engl J Med"},{"key":"BFncpgasthep1340_CR67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa062897","volume":"357","author":"S Schreiber","year":"2007","unstructured":"Schreiber S et al. (2007) Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med 357: 239\u2013250","journal-title":"N Engl J Med"},{"key":"BFncpgasthep1340_CR68","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1053\/j.gastro.2007.05.006","volume":"133","author":"M Clark","year":"2007","unstructured":"Clark M et al. (2007) American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21\u201323, 2006. Gastroenterology 133: 312\u2013339","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR69","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T et al. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295: 2275\u20132285","journal-title":"JAMA"},{"key":"BFncpgasthep1340_CR70","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/ard.2004.033241","volume":"64","author":"J Askling","year":"2005","unstructured":"Askling J et al. (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64: 1414\u20131420","journal-title":"Ann Rheum Dis"},{"key":"BFncpgasthep1340_CR71","first-page":"A178","volume":"132","author":"GR Lichtenstein","year":"2007","unstructured":"Lichtenstein GR et al. (2007) Safety of infliximab and other Crohn's disease therapies\u2014Treat Registry. Data with nearly 20,000 patient-years of follow-up [abstract]. Gastroenterology 132: A178","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1340_CR72","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1365-2036.2006.02878.x","volume":"23","author":"BE Sands","year":"2006","unstructured":"Sands BE et al. (2006) Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study. Aliment Pharmacol Ther 23: 1127\u20131136","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep1340_CR73","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa020888","volume":"348","author":"F Baert","year":"2003","unstructured":"Baert F et al. (2003) Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 348: 601\u2013608","journal-title":"N Engl J Med"},{"key":"BFncpgasthep1340_CR74","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/01.MIB.0000161536.97412.41","volume":"11","author":"DS Fefferman","year":"2005","unstructured":"Fefferman DS and Farrell RJ (2005) Immunogenicity of biological agents in inflammatory bowel disease. Inflamm Bowel Dis 11: 497\u2013503","journal-title":"Inflamm Bowel Dis"},{"key":"BFncpgasthep1340_CR75","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1517\/14712598.7.8.1233","volume":"7","author":"CJ van der Woude","year":"2007","unstructured":"van der Woude CJ and Hommes DW (2007) Biologics in Crohn's disease: searching indicators for outcome. Expert Opin Biol Ther 7: 1233\u20131243","journal-title":"Expert Opin Biol Ther"},{"key":"BFncpgasthep1340_CR76","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","volume":"44","author":"AC Mackey","year":"2007","unstructured":"Mackey AC et al. (2007) Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 44: 265\u2013267","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"BFncpgasthep1340_CR77","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2165\/00003495-200767120-00005","volume":"67","author":"G Veres","year":"2007","unstructured":"Veres G et al. (2007) Infliximab therapy in children and adolescents with inflammatory bowel disease. Drugs 67: 1703\u20131723","journal-title":"Drugs"},{"key":"BFncpgasthep1340_CR78","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/gut.2006.115980","volume":"56","author":"SB Hanauer","year":"2007","unstructured":"Hanauer SB (2007) Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk? Gut 56: 1181\u20131183","journal-title":"Gut"},{"key":"BFncpgasthep1340_CR79","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMoa041109","volume":"352","author":"JR Korzenik","year":"2005","unstructured":"Korzenik JR et al. (2005) Sargramostim for active Crohn's disease. N Engl J Med 352: 2193\u20132201","journal-title":"N Engl J Med"},{"key":"BFncpgasthep1340_CR80","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1046\/j.1365-2036.2003.01790.x","volume":"18","author":"U Mahadevan","year":"2003","unstructured":"Mahadevan U et al. (2003) Fistula response to methotrexate in Crohn's disease: a case series. Aliment Pharmacol Ther 18: 1003\u20131008","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep1340_CR81","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/00042737-200409000-00018","volume":"16","author":"SY Soon","year":"2004","unstructured":"Soon SY et al. (2004) Experience with the use of low-dose methotrexate for inflammatory bowel disease. Eur J Gastroenterol Hepatol 16: 921\u2013926","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFncpgasthep1340_CR82","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJM199502023320503","volume":"332","author":"BG Feagan","year":"1995","unstructured":"Feagan BG et al. (1995) Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 332: 292\u2013297","journal-title":"N Engl J Med"},{"key":"BFncpgasthep1340_CR83","first-page":"1721","volume":"103","author":"Y Fukuda","year":"2008","unstructured":"Fukuda Y et al. (2008) Oral spherical adsorptive carbon for the treatment of intractable anal fistulas in Crohn's disease: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 103: 1721\u20131729","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep1340_CR84","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s11605-006-0068-9","volume":"11","author":"A Fichera","year":"2007","unstructured":"Fichera A and Michelassi F (2007) Surgical treatment of Crohn's disease. J Gastrointest Surg 11: 791\u2013803","journal-title":"J Gastrointest Surg"},{"issue":"Suppl 4","key":"BFncpgasthep1340_CR85","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1463-1318.2007.01372.x","volume":"9","author":"JG Williams","year":"2007","unstructured":"Williams JG et al. (2007) The treatment of anal fistula: ACPGBI position statement. Colorectal Dis 9 (Suppl 4): 18\u201350","journal-title":"Colorectal Dis"},{"key":"BFncpgasthep1340_CR86","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/BF02058706","volume":"39","author":"YP Sangwan","year":"1996","unstructured":"Sangwan YP et al. (1996) Perianal Crohn's disease. Results of local surgical treatment. Dis Colon Rectum 39: 529\u2013535","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR87","first-page":"133","volume":"169","author":"DH Levien","year":"1989","unstructured":"Levien DH et al. (1989) Surgical treatment of anorectal fistula in patients with Crohn's disease. Surg Gynecol Obstet 169: 133\u2013136","journal-title":"Surg Gynecol Obstet"},{"key":"BFncpgasthep1340_CR88","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/BF02053687","volume":"34","author":"JG Williams","year":"1991","unstructured":"Williams JG et al. (1991) Fistula-in-ano in Crohn's disease. Results of aggressive surgical treatment. Dis Colon Rectum 34: 378\u2013384","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR89","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/bjs.4466","volume":"91","author":"GN Buchanan","year":"2004","unstructured":"Buchanan GN et al. (2004) Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula. Br J Surg 91: 476\u2013480","journal-title":"Br J Surg"},{"key":"BFncpgasthep1340_CR90","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/gut.37.5.696","volume":"37","author":"F Makowiec","year":"1995","unstructured":"Makowiec F et al. (1995) Clinical course of perianal fistulas in Crohn's disease. Gut 37: 696\u2013701","journal-title":"Gut"},{"key":"BFncpgasthep1340_CR91","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9610(99)00180-4","volume":"178","author":"N Hyman","year":"1999","unstructured":"Hyman N (1999) Endoanal advancement flap repair for complex anorectal fistulas. Am J Surg 178: 337\u2013340","journal-title":"Am J Surg"},{"key":"BFncpgasthep1340_CR92","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/BF02553995","volume":"27","author":"CA Vasilevsky","year":"1984","unstructured":"Vasilevsky CA and Gordon PH (1984) The incidence of recurrent abscesses or fistula-in-ano following anorectal suppuration. Dis Colon Rectum 27: 126\u2013130","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR93","first-page":"147","volume":"64","author":"JS Joo","year":"1998","unstructured":"Joo JS et al. (1998) Endorectal advancement flap in perianal Crohn's disease. Am Surg 64: 147\u2013150","journal-title":"Am Surg"},{"key":"BFncpgasthep1340_CR94","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/BF02554276","volume":"30","author":"IT Jones","year":"1987","unstructured":"Jones IT et al. (1987) The use of transanal rectal advancement flaps in the management of fistulas involving the anorectum. Dis Colon Rectum 30: 919\u2013923","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR95","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1007\/s10350-004-7248-z","volume":"45","author":"N Mizrahi","year":"2002","unstructured":"Mizrahi N et al. (2002) Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum 45: 1616\u20131621","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR96","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11605-006-0029-3","volume":"11","author":"MH Mueller","year":"2007","unstructured":"Mueller MH et al. (2007) Risk of fecal diversion in complicated perianal Crohn's disease. J Gastrointest Surg 11: 529\u2013537","journal-title":"J Gastrointest Surg"},{"key":"BFncpgasthep1340_CR97","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1097\/01.sla.0000161030.25860.c1","volume":"241","author":"S Galandiuk","year":"2005","unstructured":"Galandiuk S et al. (2005) Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg 241: 796\u2013801","journal-title":"Ann Surg"},{"key":"BFncpgasthep1340_CR98","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10350-005-0288-1","volume":"49","author":"EK Johnson","year":"2006","unstructured":"Johnson EK et al. (2006) Efficacy of anal fistula plug vs. fibrin glue in closure of anorectal fistulas. Dis Colon Rectum 49: 371\u2013376","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR99","doi-asserted-by":"crossref","unstructured":"Committee Consensus Statement (2008) The Surgisis\u00ae AFP\u2122 anal fistula plug: report of a consensus conference. Colorectal Dis 10: 17\u201320","DOI":"10.1111\/j.1463-1318.2007.01423.x"},{"key":"BFncpgasthep1340_CR100","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00384-007-0398-4","volume":"23","author":"O Schwandner","year":"2008","unstructured":"Schwandner O et al. (2008) Initial experience on efficacy in closure of cryptoglandular and Crohn's transsphincteric fistulas by the use of the anal fistula plug. Int J Colorectal Dis 23: 319\u2013324","journal-title":"Int J Colorectal Dis"},{"key":"BFncpgasthep1340_CR101","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s10350-006-0695-y","volume":"49","author":"L O'Connor","year":"2006","unstructured":"O'Connor L et al. (2006) Efficacy of anal fistula plug in closure of Crohn's anorectal fistulas. Dis Colon Rectum 49: 1569\u20131573","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR102","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s10350-003-0076-8","volume":"47","author":"R Loungnarath","year":"2004","unstructured":"Loungnarath R et al. (2004) Fibrin glue treatment of complex anal fistulas has low success rate. Dis Colon Rectum 47: 432\u2013436","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR103","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF02054227","volume":"38","author":"PR Williamson","year":"1995","unstructured":"Williamson PR et al. (1995) Twenty-year review of the surgical management of perianal Crohn's disease. Dis Colon Rectum 38: 389\u2013392","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR104","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/BF02235190","volume":"42","author":"T Yamamoto","year":"1999","unstructured":"Yamamoto T et al. (1999) Persistent perineal sinus after proctocolectomy for Crohn's disease. Dis Colon Rectum 42: 96\u2013101","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR105","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/bjs.4872","volume":"92","author":"MH Collie","year":"2005","unstructured":"Collie MH et al. (2005) Myocutaneous flaps promote perineal healing in inflammatory bowel disease. Br J Surg 92: 740\u2013741","journal-title":"Br J Surg"},{"key":"BFncpgasthep1340_CR106","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/110241500750009311","volume":"166","author":"J Rius","year":"2000","unstructured":"Rius J et al. (2000) Gracilis transposition in complicated perianal fistula and unhealed perineal wounds in Crohn's disease. Eur J Surg 166: 218\u2013222","journal-title":"Eur J Surg"},{"key":"BFncpgasthep1340_CR107","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/bjs.4613","volume":"91","author":"B Singh","year":"2004","unstructured":"Singh B et al. (2004) Perianal Crohn's disease. Br J Surg 91: 801\u2013814","journal-title":"Br J Surg"},{"key":"BFncpgasthep1340_CR108","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00000658-199102000-00010","volume":"213","author":"JJ Bauer","year":"1991","unstructured":"Bauer JJ et al. (1991) Transvaginal approach for repair of rectovaginal fistulae complicating Crohn's disease. Ann Surg 213: 151\u2013158","journal-title":"Ann Surg"},{"key":"BFncpgasthep1340_CR109","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1463-1318.2007.01232.x","volume":"9","author":"K Songne","year":"2007","unstructured":"Songne K et al. (2007) Treatment of anovaginal or rectovaginal fistulas with modified Martius graft. Colorectal Dis 9: 653\u2013656","journal-title":"Colorectal Dis"},{"key":"BFncpgasthep1340_CR110","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/BF02053988","volume":"39","author":"PM Sagar","year":"1996","unstructured":"Sagar PM et al. (1996) Long-term results of ileal pouch\u2013anal anastomosis in patients with Crohn's disease. Dis Colon Rectum 39: 893\u2013898","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR111","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/BF02234789","volume":"44","author":"O Zmora","year":"2001","unstructured":"Zmora O et al. (2001) Reoperative abdominal and perineal surgery in ileoanal pouch patients. Dis Colon Rectum 44: 1310\u20131314","journal-title":"Dis Colon Rectum"},{"key":"BFncpgasthep1340_CR112","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s00464-003-8904-4","volume":"18","author":"JP Regan","year":"2004","unstructured":"Regan JP and Salky BA (2004) Laparoscopic treatment of enteric fistulas. Surg Endosc 18: 252\u2013254","journal-title":"Surg Endosc"},{"key":"BFncpgasthep1340_CR113","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(08)60304-9","volume":"371","author":"G D'Haens","year":"2008","unstructured":"D'Haens G et al. (2008) Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 371: 660\u2013667","journal-title":"Lancet"},{"key":"BFncpgasthep1340_CR114","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s11605-007-0284-y","volume":"11","author":"MA da Luz","year":"2007","unstructured":"da Luz MA et al. (2007) Laparoscopic surgery for patients with Crohn's colitis: a case-matched study. J Gastrointest Surg 11: 1529\u20131533","journal-title":"J Gastrointest Surg"},{"key":"BFncpgasthep1340_CR115","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.surg.2007.08.004","volume":"142","author":"A Fichera","year":"2007","unstructured":"Fichera A et al. (2007) Laparoscopy or conventional open surgery for patients with ileocolonic Crohn's disease? A prospective study. Surgery 142: 566\u2013571","journal-title":"Surgery"}],"container-title":["Nature Clinical Practice Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep1340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep1340","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpgasthep1340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep1340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T08:21:30Z","timestamp":1709972490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpgasthep1340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,20]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BFncpgasthep1340"],"URL":"https:\/\/doi.org\/10.1038\/ncpgasthep1340","relation":{},"ISSN":["1743-4378","1743-4386"],"issn-type":[{"value":"1743-4378","type":"print"},{"value":"1743-4386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,20]]}}}